Search Results

E6446 5 mg  | 99.41%

TargetMol

E6446 inhibits Toll-like receptor (TLR)7 and 9 signaling. E6446 works in a variety of human and mouse cell types and inhibits DNA-TLR9 interaction in vitro. When administered to mice, this compound suppress responses to challenge doses of cytidine-phosphate-guanidine (CpG)-containing DNA, which stimulates TLR9.

More Information Supplier Page

E6446 2 mg  | 99.41%

TargetMol

E6446 inhibits Toll-like receptor (TLR)7 and 9 signaling. E6446 works in a variety of human and mouse cell types and inhibits DNA-TLR9 interaction in vitro. When administered to mice, this compound suppress responses to challenge doses of cytidine-phosphate-guanidine (CpG)-containing DNA, which stimulates TLR9.

More Information Supplier Page

PF-06260933 5 mg  | Purity Not Available

TargetMol

PF-06260933 is a highly selective small-molecule MAP4K4 inhibitor with IC50s of 3.7 and 160 nM for kinase and cell, respectively.

More Information Supplier Page

KKL-10 10 mg  | Purity Not Available

TargetMol

KKL-10, a ribosome rescue inhibitor, has broad-spectrum antimicrobial activity against bacteria.

More Information Supplier Page

KKL-10 1 mg  | Purity Not Available

TargetMol

KKL-10, a ribosome rescue inhibitor, has broad-spectrum antimicrobial activity against bacteria.

More Information Supplier Page

PF-3758309 hydrochloride 5 mg  | 98.11%

TargetMol

PF-3758309, also known as PF-03758309, is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PAK4 inhibitor PF-03758309 binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a […]

More Information Supplier Page

PF-3758309 hydrochloride 50 mg  | 98.11%

TargetMol

PF-3758309, also known as PF-03758309, is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PAK4 inhibitor PF-03758309 binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a […]

More Information Supplier Page

PF-3758309 hydrochloride 25 mg  | 98.11%

TargetMol

PF-3758309, also known as PF-03758309, is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PAK4 inhibitor PF-03758309 binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a […]

More Information Supplier Page